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Cannabinoid 1 receptor mediation of spinal cord ischemic tolerance
induced by limb remote ischemia preconditioning in rats
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Lize Xiong, MD, PhD
Objective: The aim of this study was to examine the influence of endogenous cannabinoids on neuroprotection of
the spinal cord afforded by limb remote ischemic preconditioning.
Methods: In experiment 1 (RIPC group), 3 cycles of limb remote ischemic preconditioning within different
episodes (2, 3, or 5 minutes) were induced before spinal cord ischemia in rats (N ¼ 5, n ¼ 8). In experiment
2, animals were pretreated intravenously by the vehicles, cannabinoid 1 (AM251, 1 mg/kg) or cannaboid 2
(AM630, 1 mg/kg) receptor antagonist 15 minutes before remote ischemic preconditioning, or else they were
subjected to a sham operation. Thirty minutes after the pretreatment, spinal cord ischemia was induced
(N ¼ 8, n ¼ 8). In experiment 3, the arachidonylethanolamide and 2-arachidonoylglycerol contents in the spinal
cord after remote ischemic preconditioning and spinal cord ischemia were detected in rats (N¼ 2, n¼ 12). Spinal
cord ischemia was induced by 12 minutes of thoracic aorta occlusion in rats. Neurologic function was assessed
24 and 48 hours after reperfusion. Histopathologic examination was performed and the number of normal neurons
in anterior spinal cord were counted.
Results: In experiment 1, 3 cycles of limb remote ischemic preconditioning (3 minutes of ischemia/3 minutes of
reperfusion) induced ischemic tolerance on the spinal cords of the rats. The RIPC group showed a significant
reduction in motor deficit index (P< .01) as well as an increase in the number of normal neurons (P< .01).
In experiment 2, the cannabinoid 1 receptor antagonist AM251 pretreatment abolished the protective effects of
remote preconditioning. In experiment 3, arachidonylethanolamide content in spinal cord was elevated by remote
ischemic preconditioning in rats.
Conclusion: These results indicated that endogenous cannabinoids, through acting on cannabinoid 1 receptors,
were involved in the neuroprotective phenomenon on spinal cords of limb remote ischemic preconditioning.
(J Thorac Cardiovasc Surg 2009;138:1409-16)
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SIschemia/reperfusion (I/R) injury is the most important
cause of paraplegia after thoracic aorta and spine surgery.
The incidence of paraplegia is 16% as reported in thora-
coabdominal aneurysm repair surgery1 and 11.8% in poste-
rior longitudinal ligament surgery.2 Although a number of
studies have shown that the risk of postoperative paraplegia
has decreased with the application of new techniques, pre-
venting spinal cord ischemic injury is still a big concern in
surgery of the thoracic aorta and spine.
In past decades, ischemic preconditioning (IPC) has been
proved to minimize I/R injury in many organs including the
spinal cord in animal models.3,4 Unfortunately, the idea of
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doi:10.1016/j.jtcvs.2009.07.014The Journal of Thoracic andexposure to brief periods of ischemia in the spinal cord be-
fore an anticipated spinal cord ischemic event does not ap-
pear to be clinically relevant. Our previous studies showed
that some nonischemic preconditioning methods, such as
hyperbaric oxygen and isoflurane preconditioning, induced
tolerance to spinal cord ischemia in an animal model.5-7 Re-
cent studies also found that the IPC-induced ischemic toler-
ance occurred not only within the same tissue, but also
between different regions as well as different organs. This
phenomenon was called remote ischemic preconditioning
(RIPC).8 RIPC has greater potential for clinical application
than classic IPC inasmuch as it can be performed in a nonvi-
tal organ, avoiding the high risk of preconditioning in the vi-
tal organ, such as the brain or the spinal cord. Because RIPC
was a more amenable and less invasive approach than other
methods, it was applied to clinical study first during coro-
nary arterial surgery and yielded satisfactory results.9,10
Despite the promising results of the clinical application of
RIPC, the mechanisms responsible for this phenomenon and
its signaling pathways still remained elusive. Numerous
studies have suggested that the endocannabinoids were im-
plicated in the protective effects of IPC through cannabinoid
(CB) receptor–dependent mechanisms.11 The pharmaco-
logic modulation of the endocannabinoid systemCardiovascular Surgery c Volume 138, Number 6 1409
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SAbbreviations and Acronyms
AEA ¼ arachidonylethanolamide
2-AG ¼ 2-arachidonoylglycerol
CB ¼ cannabinoid
IPC ¼ ischemic preconditioning
I/R ¼ ischemia/reperfusion
MDI ¼ motor deficit index
PaCO2 ¼ arterial carbon dioxide tension
PaO2 ¼ arterial oxygen tension
RIPC ¼ remote ischemic preconditioning
represented a promising strategy in various cardiovascular,
inflammatory, and metabolic disorders. A recent study has
demonstrated that endogenous CBs, by acting on CB2 re-
ceptors, were involved in the cardioprotective phenomenon
of RIPC, induced by mesenteric artery occlusion and reper-
fusion.12 However, whether the endocannabinoid system
mediated the spinal cord ischemic tolerance induced by
limb RIPC remains to be further investigated.
Therefore, the primary objectives of the present study
were to determine (1) whether limb RIPC could induce spi-
nal cord ischemic tolerance and (2) whether it was mediated
by endocannabinoids and CB receptors.
MATERIALS AND METHODS
The study was approved by the Ethics Committee for Animal Experi-
mentation and all procedures were conducted according to the Guidelines
for Animal Experimentation of our institutes. All animals were neurologi-
cally intact before anesthesia and were studied at Xijing Hospital, Fourth
Military Medical University (Xi’an, China).
Animals
All experiments were performed on male Sprague–Dawley rats (300–
350 g). Rats were housed in standard cages with corncob bedding. Animals
had access to food and water ad libitum and were housed separately after
surgery. A 12-hour light/dark cycle (lights on at 7:00 AM) was maintained.
Limb RIPC and Spinal Cord Ischemia
The right femoral artery was separated below the right groin ligament for
later induction of femoral artery occlusion (RIPC). Spinal cord ischemia
was induced by the previously described technique.13 In brief, anesthesia
was induced with 4% isoflurane in oxygen and maintained with 1.5% to
2% isoflurane. Body temperature was maintained at 37 C using a homeo-
thermic blanket system. Distal arterial blood pressure and heart rate were
monitored by a tail artery catheter (Colin BP 508; Colin Corporation,
Komaki City, Japan). The blood samples were collected for arterial oxygen
tension (PaO2), arterial carbon dioxide tension (PaCO2), pH, and plasma glu-
cose measurement (Rapidlab 1200; Bayer, Leverkusen, Germany) from the
tail artery. The left carotid artery was cannulated with a 20-gauge polytetra-
fluoroethylene catheter for blood withdrawal and proximal arterial blood
pressure. The left jugular vein was cannulated for intravenous drug injec-
tions. Spinal cord ischemia was induced by passage of a 2F Fogarty catheter
(American V. Mueller, CV 1035; Baxter, Irvine, Calif) through the left fem-
oral artery to the descending thoracic aorta so that the tip reached the level of
the left subclavian artery (10.8–11.4 cm from the site of insertion). The intra-
aortic balloon catheter was inflated with 0.05 mL of saline, and occlusion of1410 The Journal of Thoracic and Cardiovascular Saortic blood flowwas confirmed by an immediate and sustained drop in distal
arterial blood pressure. Systemic hypotension (45 mm Hg) was maintained
during occlusion by a blood-collecting circuit (37.5 C) connected to the ca-
rotid artery and positioned at a height of 60 cm (45 mm Hg). After ischemia,
the balloon was deflated, and the blood was reinfused during a 60-second
period. After blood reinfusion, 4 mg of protamine sulfate was administered
subcutaneously. Stabilization of arterial blood pressure was then monitored
for an additional 10 minutes, after which the arterial lines were removed
and wounds were closed. Rats were then allowed to recover.
Neurologic and Histopathologic Evaluations
The animals were neurologically assessed at 24 and 48 hours after reper-
fusion by an observer who was unaware of the grouping. To evaluate the
neuronal damage, the observer evaluated motor function deficits in the
hind limbs according to the criteria as reported.14 Motor deficit scores
were graded according to the following scale: (a) walking/use of hind limbs:
0 ¼ normal, 1 ¼ toes flat under the body when walking, 2 ¼ knuckle walk-
ing, 3¼movement of the hind limbs but unable to walk, and 4¼ no move-
ment, dragging hind limbs; (b) placing/stepping reflex: 0 ¼ normal, 1 ¼
weak, and 2 ¼ not stepping. Each motor deficit score was obtained by add-
ing the scores for scales a and b.
A histopathologic evaluation was performed in the spinal cord for 48
hours after reperfusion. Rats were deeply anesthetized with sodium pento-
barbital (60 mg/kg). Transcardiac perfusion and fixation were performed
with 200 mL of 0.9% saline solution followed by 250 mL of 4% parafor-
maldehyde in 0.1 mol/L phosphate buffer. The spinal cord was removed and
postfixed in the same fixative overnight. Three representative sections were
taken from L4 to L6 segments and were stained with hematoxylin and eosin
for histopathologic evaluation. Neuronal injury was evaluated at a magnifi-
cation of 3200 by an observer who was unaware of the grouping. The re-
maining normal neurons in the ischemic ventral spinal cord in each
animal, judged by their morphologic appearance, were counted in 3 sections
selected randomly from the L4 to L6 segment and then averaged. The num-
bers of normal neurons per section were compared among groups.
Experimental Protocol
The statistical significance of histopathologic outcomewas considered to
be the end point in experiment 1 and experiment 2. The statistical signifi-
cance of arachidonylethanolamide (AEA) or 2-arachidonoylglycerol
(2-AG) content was considered to be the end point of experiment 3. The
power of inequality test is set as 0.8 (alpha ¼ .05). Referring to our prelim-
inary study, we assumed a difference in normal motor neurons and AEA
content in spinal cord of about 20/slice and 0.4 pmol/mg between the
RIPC group and control group. The Produce Application and Support Soft-
ware (PASS; Prentke Romich Company,Wooster, Ohio) was used to calcu-
late the sample size.
Experiment 1: Effect of repeated limb RIPC on spinal
cord I/R injury. A total of 40 male Sprague–Dawley rats were ran-
domly divided into 5 groups (n ¼ 8 in each group):
1. SHAM GROUP: Rats were operated on in the same way as in the
other groups but without limb IPC and spinal cord ischemia.
2. CONTROL GROUP: After rats were anesthetized with 1% to 2%
isoflurane for 30 minutes, spinal cord ischemia was induced.
3. RIPC2 MIN-3C GROUP: Three 2-minute cycles of right femoral
artery occlusion and reperfusion were induced before spinal
cord I/R.
4. RIPC3 MIN-3C GROUP: Three 3-minute cycles of right femoral
artery occlusion and reperfusion were induced before spinal
cord I/R.
5. RIPC5 MIN-3C GROUP: Three 5-minute cycles of right femoral
artery occlusion and reperfusion were induced before spinal
cord I/R.urgery c December 2009
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(control group), the rats were subjected to spinal cord ischemia for 12 min-
utes except in the sham operation group.
Experiment 2: Effect of CB1 receptor or CB2 receptor
antagonist on the ischemic tolerance induced by RIPC.
Sixty-four male Sprague–Dawley rats were randomly divided into 8 groups
(n ¼ 8 in each group):
1. G1 (CONTROL): The right femoral artery was isolated without oc-
clusion, followed by spinal I/R protocol.
2. G2 (RIPC): Three 3-minute cycles of right femoral artery occlu-
sion and reperfusion were induced before spinal cord I/R.
3. G3 (AM251þRIPC): CB1 receptor antagonist AM251 (Tocris
Bioscience, Bristol, United Kingdom; 1 mg/kg) was intrave-
nously administered 15 minutes before right femoral artery
occlusion.
4. G4 (AM630þRIPC): CB2 receptor antagonist AM630 (Tocris;
1 mg/kg) was intravenously administered 15 minutes before
right femoral artery occlusion.
5. G5 (VEHICLEþ RIPC): Vehicle was intravenously administered
15 minutes before right femoral artery occlusion (3 minutes)
and reperfusion (3 minutes, 3 cycles) before spinal cord I/R pro-
tocol.
6. G6 (AM251): AM251 (Tocris; 1 mg/kg) was intravenously ad-
ministered 15 minutes before the sham operation of RIPC.
7. G7 (AM630): AM630 (Tocris;, 1 mg/kg) was intravenously ad-
ministered 15 minutes before the sham operation of RIPC.
8. G8 (VEHICLE): Vehicle was intravenously administered 15 min-
utes before the sham operation of RIPC.
Thirty minutes after preconditioning or 45 minutes after chemical pre-
treatment, the rats were subjected to spinal cord ischemia for 12 minutes.
The time of total anesthesia was identical in the 8 groups.
Experiment 3. The contents of AEA and 2-AG in lumbar
spinal cord samples before and after spinal cord ische-
mia. Twenty-four rats were divided into 2 groups: control group and
RIPC group (n ¼ 12 in each group). Animals were humanely killed before
(30 minutes after RIPC or sham operation) or 1 hour after spinal cord ische-
mia. The spinal cord was removed within 1 minute (20 C). A sample of 1
cm from L4 to L6 segments of spinal cord was frozen in Dry Ice and then
stored at80 C in a refrigerator. For endocannabinoid measurement, spinal
cord samples from the rats of control or RIPC groups (n ¼ 6 in each time
point) were sampled.
Endocannabinoid Measurement
Endocannabinoids were extracted from the spinal cords. Animals were
killed at specified time points. The spinal cord were removed and frozen
on Dry Ice less than 1 minute after death. Tissue was stored at80 C until
extraction. Tissue was homogenized with a glass rod and followed by incu-
bation overnight at10 C to precipitate proteins. A 0.2-mL aliquot of each
sample was transferred to a polypropylene tube. Then, 2 mL of ethyl acetate
(liquid chromatography grade) was added to the tube and vortex mixed for 1
minute. After centrifugation (10 minutes at 3000g), the supernatant was
transferred to a fresh tube. The deposition was then added to 2 mL ethyl ac-
etate and operated in the same way. Next the supernatant was transferred to
a new glass tube and evaporated under N2 gas. The final residue was dis-
solved in 50 mLmobile phase with vortex mixing for 60 seconds. An aliquot
of 10 mL was subjected to the liquid chromatography/electrospray ioniza-
tion tandem mass spectrometry.
AEA and 2-AG were separated on a C18 (50 3 2.1 mm, 5 mm) reverse-
phase column(Waters Symmetry; Waters Corporation, Milford, Mass). The
mobile phase composition was a mixture of water/acetonitrile (10:90, vol/The Journal of Thoracic and Cvol) at a flow rate of 0.2 mL/min. AEA and 2-AG were separated on a re-
versed-phase column (Symmetry C18 column, 50 3 2.1 mm, 5 mm) with
an isocratic mobile phase consisting of 0.1% acetic acid water and acetoni-
trile (10:90, vol/vol). The column temperature and flow rate were 25 C and
0.2 mL/min, respectively. The mass spectrometer was operated using elec-
trospray ionization with a capillary voltage ofþ3500 V. The positive ion
multiple-reaction–monitoring mode analysis was performed using argon
as the collision gas. Standard solutions of AEA and 2-AG were applied to
optimize the detecting condition in the presence of liquid chromatography
mobile phase. Data acquisition and processing were performed by Mas-
sLynx 4.1 software package (Waters Corporation).The AEA and 2-AG
levels were normalized to the total weight of the wet tissue (pmol/mg tissue).
Statistical Analysis
Statistical analysis of physiologic data, number of normal neurons in the
anterior cord, and level of endocannabinoids in the spinal cord were per-
formed by one-way analysis of variance followed by a Student–New-
man–Keuls test for multiple comparisons. For analysis of neurologic
outcome in the individual occlusion group, significant overall values were
obtained with a Kruskal–Wallis test. Specific comparisons between exper-
imental groups were performed with the Mann–WhitneyU test for indepen-
dent means. Data were expressed as mean  SEM.
RESULTS
Experiment 1
Physiologic variables. The hemodynamic variables are
shown in Figure 1. Except for the sham group, the rectal tem-
perature, arterial pH, PaCO2, PaO2, and blood glucose con-
centrations were similar in all the groups. In groups in
which spinal cord ischemia was induced, blood glucose
was elevated and pH was decreased after reperfusion, but
there was no difference among groups (data are not shown).
Five minutes after reperfusion, the value of the distal blood
pressure had recovered to nearly preischemic level (see
Figure 1).
Neurologic outcome. All animals survived until the final
neurologic behavior assessment at 48 hours after reperfu-
sion. There was no neurologic change in the sham group,
and all of the other groups of rats showed motor deficit in
varying degrees. The neurologic outcome in the RIPC3
min-3c group was better than that of the control, RIPC2
min-3c, and RIPC5 min-3c groups, respectively (P< .01).
Three rats in the RIPC3 min-3c group showed complete nor-
mal motor function (motor deficit index, MDI ¼ 0). The
hind-limb MDIs of 5 groups at 48 hours after reperfusion
are shown in Figure 2, A.
Histopathologic evaluation. The number of normal neu-
rons in the RIPC3 min-3c group was significantly greater
than that in the RIPC2 min-3c, RIPC5 min-3c, and control
groups (P< .01). No difference was found in the number
of normal neurons at the anterior spinal cord among the con-
trol, RIPC2 min-3c, and RIPC5 min-3c (Figure 2, B).
Experiment 2
Physiologic variables. The hemodynamics, rectal temper-
ature, arterial pH, PaCO2, PaO2, and blood glucoseardiovascular Surgery c Volume 138, Number 6 1411
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Sham, Sham operation without spinal cord ischemia;Control, sham operation of remote preconditioning before spinal cord ischemia; RIPC2-3c, rats accepted
remote ischemic preconditioning (3 cycles, 2 minutes of ischemia/2 minutes of reperfusion) before spinal cord ischemia; RIPC3-3c, rats accepted remote
ischemic preconditioning (3 cycles, 3 minutes of ischemia/3 minutes of reperfusion) before spinal cord ischemia; RIPC5-3c, rats accepted remote ischemic
preconditioning (3 cycles, 5 minutes of ischemia/5 minutes of reperfusion) before spinal cord ischemia. I, Ischemia; R, reperfusion. The data are expressed as
mean  SEM. ***P< .001 vs sham.concentration changes were similar to those in experiment 1
(data not shown).
Neurologic outcome. All animals survived until the final
neurologic behavior assessment at 48 hours after reperfu-
sion. The neurologic outcome in the RIPC group was better
than that of the control (P<.05) and AM251þRIPC groups
(P<.01). The MDI in RIPC, AM630þRIPC, and vehicleþ
RIPC3 groups did not show significant differences. There
was no significant difference among control, AM251 þ
RIPC, AM251, AM630, and vehicle groups. The hind-
limb MDIs at 48 hours after reperfusion are shown in
Figure 3, A.
Histopathologic evaluation. The number of normal motor
neurons in the RIPC group was significantly more than that
in the control (P< .05) and AM251þRIPC groups (P<
.05). There was no significance among RIPC, AM630 þ
RIPC, and vehicleþRIPC groups. The ventral neurons in
AM251, AM630, and vehicle groups were damaged seri-
ously, and the number of normal neurons among these
groups did not show significant differences (Figure 3, B).1412 The Journal of Thoracic and Cardiovascular SExperiment 3
Levels of AEA and 2-AG in lumbar spinal cord before and
after spinal cord ischemia in the RIPC and control groups are
shown in Figure 4. The preischemic AEA level in the RIPC
group was higher than that in the control group (P< .05).
The results indicated that RIPC (3 cycles of 3 minutes of
limb I/R) stimulated the formation of AEA in the lumbar spi-
nal cord. The postischemic AEA level did not show signifi-
cant difference between the 2 groups. There was no
significant difference in 2-AG content in lumber spinal
cord at corresponding times between the 2 groups.
DISCUSSION
This study provided evidence that the endogenous CB
system contributes to the neuroprotective effects of limb
RIPC on spinal cord ischemia, conferred by a brief episode
of femoral artery occlusion and reperfusion. Our study also
proved that 3 cycles of 3 minutes of ischemia and 3 minutes
of reperfusion provided the optimal conditions of limb RIPC
on the induction of spinal cord ischemic tolerance in the raturgery c December 2009
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cord. Furthermore, the neuroprotective effects of limb
RIPC were reversed by pretreatment with CB1 receptor an-
tagonist. These observations suggested that spinal cord is-
chemic tolerance induced by limb RIPC was mediated
through CB1 receptors.
Spinal cord injury after a successful surgical operation on
the thoracic aorta is an unpredictable but disastrous compli-
cation. The causes of acute spinal cord dysfunction were be-
lieved to be the result of a spinal cord I/R injury during aortic
crossclamping. Excitatory amino acids, heat shock protein,
and free radicals were all suggested to play important roles
in the development of spinal cord ischemic injury. However,
ameliorative measures, including hypothermia and free rad-
ical scavengers, were still inadequate. IPC has been shown
to provide spinal cord protection from ischemic injury.15,16
However, exposure of the spinal cord to a brief period of is-
chemia before an anticipated ischemic event did not appear
to be clinically relevant. RIPC was a protective phenomenon
FIGURE 2. Neurologic outcome 48 hours after reperfusion (A) and the
number of normal neurons in the anterior spinal cord in experiment 1 (B).
(**P < 0.01 vs. control). Sham, Sham operation without spinal cord
ischemia; Control, sham operation of remote preconditioning before spinal
cord ischemia; RIPC2-3c, rats accepted remote ischemic preconditioning
(3 cycles, 2 minutes of ischemia/2 minutes of reperfusion) before spinal
cord ischemia; RIPC3-3c, rats accepted remote ischemic preconditioning
(3 cycles, 3 minutes of ischemia/3 minutes of reperfusion) before spinal
cord ischemia; RIPC5-3c, rats accepted remote ischemic preconditioning
(3 cycles, 5 minutes of ischemia/5 minutes of reperfusion) before spinal
cord ischemia.
FIGURE 3. Neurologic outcome 48 hours after reperfusion (A) and the
number of normal neurons in the anterior spinal cord in experiment 2 (B).
*P< .05 vs G1; **P< 0.01 vs G1; #P< .05 vs G2. G1, Control group;
G2, rats accepted remote ischemic preconditioning (3 cycles, 3 minutes of
ischemia/3 minutes of reperfusion) before spinal cord ischemia; G3,
AM251 was intravenously administered 15 minutes before remote precon-
ditioning; G4, AM630 was intravenously administered 15 minutes before
remote preconditioning; G5, vehicle was intravenously administered
15 minutes before remote preconditioning; G6, AM251 was intravenously
administered 15 minutes before sham operation of remote preconditioning;
G7, AM630 was intravenously administered 15 minutes before sham oper-
ation of remote preconditioning; G8, vehicle was intravenously adminis-
tered 15 minutes before sham operation of remote preconditioning.The Journal of Thoracic and Cardiovascular Surgery c Volume 138, Number 6 1413
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has demonstrated that RIPC of the kidney can induce ische-
mic tolerance in the spinal cord in a rabbit model.18 How-
ever, inducing a brief period of kidney ischemia before an
anticipated spinal cord ischemic event seemed unsafe and
not practicable.
The current study confirmed that 3 cycles of brief limb I/R
episodes (RIPC) applied before aortic occlusion result in sig-
nificant protection of the spinal cord from ischemic injury in
a rat model, although neurologic function in the RIPC3 min-
3c group was better than that in the control group. The num-
ber of normal motor neurons in the ventral horn in the RIPC3
min-3c and RIPC5 min-3c groups was higher than that in the
control group. Inasmuch as it was easier and safer to perform
a limb RIPC than to induce brief ischemia on the aorta itself
before the thoracic aorta surgery, our finding has significant
FIGURE4. Levels of arachidonylethanolamide (AEA) (A) and 2-arachido-
noylglycerol (2-AG) (B) in lumbar spinal cord at preischemia (30 minutes
after limb remote preconditioning [RIPC] or sham operation) and postische-
mia (1 hour after spinal cord ischemia) derived from RIPC and control
groups. Data are expressed as mean SEM; n¼ 6 per group. *P<.05 com-
pared with controls.Control group, Sham operation of remote precondition-
ing was performed before spinal cord ischemia; RIPC group, limb remote
preconditioning was induced before spinal cord ischemia.1414 The Journal of Thoracic and Cardiovascular Suclinical applications in the future. The spinal cord ischemia
model that was used in the present study is referred to in pre-
vious reports.13 This model was a reliable and stable animal
model for studying neuroprotective manipulations and
mechanisms on spinal cord in rodents.
The endocannabinoid system represented a pivotal neuro-
protective mechanism in ischemic and traumatic neuronal
injuries. Modulation of immune responses, activation of cy-
toprotective signaling pathways, and antioxidant properties
of CBs have been suggested to be involved in the mecha-
nisms of the neuroprotective effects of the endocannabinoid
system.19 Previous study demonstrated that CB receptor ag-
onist attenuated hippocampal neuronal loss after cerebral
ischemia in a CB1-dependent manner.20 Knockout of CB1
elevated mortality and increased infarct size from cerebral
ischemia in mice.21 A protective effect on spinal cord neu-
rons was also induced by the pharmacologic modulation
of the endocannabinoid system.22 However, the role of en-
docannabinoids in spinal cord ischemia and RIPC-induced
ischemic tolerance remained to be elucidated.
Several studies have proved that an increase of endocan-
nabinoid levels was found after cerebral and myocardial I/R
injury.23,24 It was speculated that the increase of endocanna-
binoid levels in tissues may related to the cell damage. Anan-
damide (AEA) and 2-AG are the natural ligands of CB
receptor that have been extensively studied so far. Nucci
and associates25 found that the I/R-induced cell death was
attenuated by the AEA stable analog methanandamide, sug-
gesting that endogenous AEA may play a protective role
against I/R injury.25 A recent study demonstrated that en-
dogenous CBs, through acting on CB2 receptors, are in-
volved in the cardioprotective phenomenon of RIPC.12
This study suggested that elevating the endogenous CB level
before a lethal ischemia can protect the fetal organ from cell
death by acting on CB receptors. In the current study, we
found that AEA, rather than 2-AG, was increased at the early
phase after RIPC and spinal cord ischemia. This was consis-
tent with most recent studies, which have found that spinal
cord lesions induced an increase of AEA levels in early
stages and an increase in 2-AG level in late stages.26 The
elevation of AEAmay be attributed to the ischemic tolerance
on spinal cord induced by RIPC.
It has been proved that I/R, but not ischemia alone, trig-
gers increases in the levels of the endocannabinoids.27 Fur-
thermore, these increases were positively correlated with the
degree of serum tumor necrosis factor-a, macrophage in-
flammatory protein-1a, and macrophage inflammatory pro-
tein-2 levels. Consistently, brief exposure of cells to various
oxidants (hydrogen peroxide, peroxynitrite) or inflamma-
tory stimuli (tumor necrosis factor-a)28 triggered marked in-
creases in cellular endocannabinoids levels. These findings
suggest that a variety of triggers, such as reactive oxygen
species, inflammatory cytokines, and others, may induce
the elevation of endocannabinoids. In previous studies byrgery c December 2009
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oxygen species in the serum and spinal cord was found after
limb RIPC.29,30 Thus we speculated that the first possibility
of elevation of endocannabinoid content in spinal cord
might be triggered by circulating reactive oxygen species in-
duced by limb ischemia. In a recent study, Opitz and co-
workers31 found that stimulation with the proinflammatory
cytokine increased the release endocannabinoids by endo-
thelial progenitor cells. Inasmuch as limb ischemia causes
the increase of inflammatory factors, the second possibility
is that elevation of endocannabinoid content might be
caused by endothelial progenitor cell– released endocanna-
binoids after limb ischemia. As mentioned above, both reac-
tive oxygen species and inflammatory factors are circulating
mediators and can activate the release of endocannabinoids
directly or indirectly (through the endothelial progenitor
cells) after limb RIPC.
Two CB receptors have been identified, CB1 and CB2 re-
ceptors. AM251 was used as a specific CB1 receptor antag-
onist and AM630 as a specific CB2 receptor antagonist in
the current study. The dosages of AM251 and AM630
were referred to previous study.12 The results showed that
neuroprotective effects induced by limb RIPC were reversed
by pretreatment of AM251 rather than AM630. These find-
ings indicated that CB1 receptor plays a crucial role in in-
ducing ischemic tolerance of RIPC in spinal cord.
The exact mechanisms of CB1 receptor on the neuropro-
tective effect are still unclear. Farquhar-Smith and associ-
ates32 found that CB1 receptors distribute mainly in the
dorsolateral funiculus, the superficial dorsal horn, and
lamina X in lumber spinal cords, which is the sensor neuron
area. Nakayama and coworkers33 demonstrated that atrial
natriuretic peptide reduces I/R-induced spinal cord injury
by enhancing sensory neuron activation in vivo. On activa-
tion, sensory neurons release calcitonin gene-related
peptide, thereby increasing endothelial production of prosta-
glandin I2, which contributes to reduction of spinal cord
injury in rats subjected to spinal cord I/R by inhibiting in-
flammatory response. In the present study, CB1 receptor an-
tagonist has reversed the protective effect of RIPC, which
implies the protective effect is mediated by CB1 receptor.
The study by Fioravanti and colleagues34 showed that con-
stitutive activity at the CB1 receptor maintains the transient
receptor potential vanilloid 1 channel in a sensitized state re-
sponsive to noxious chemical stimuli. Considering the previ-
ous reports with our findings in the current study, we
speculated that RIPC induces an increase of endocannabi-
noids in the spinal cord, the latter bind to CB1 receptor,
which activate transient receptor potential vanilloid 1 chan-
nel and induce calcitonin gene-related peptide release. The
process elevated the level of prostaglandin I2 in the spinal
cord, which induces spinal cord ischemic tolerance in the rat.
In the current study, we only investigated the RIPC effect
at 24 and 48 hours after reperfusion, which is a relativelyThe Journal of Thoracic and Cashort period of time, to demonstrate the manifestation of
delayed neuronal necrosis from apoptotic mechanisms, or
other mechanisms related to delayed neuronal necrosis.
Meanwhile, the exact mechanisms of endocannabinoid ele-
vation in the spinal cord after limb ischemia (RIPC) were not
clarified by this study. We speculated that both reactive
oxygen species and endothelial progenitor cell mechanisms
are involved in the elevation of endocannabinoids in the
spinal cord after RIPC. All of these need to be elucidated
in a future study.
In summary, the findings of this study provide evidence of
the contribution of endogenous cannabinoids to neuropro-
tection induced by a brief episode of femoral artery occlu-
sion and reperfusion. These neuroprotective effects of
endogenous cannabinoids on I/R-induced injury in spinal
cord are mediated by CB1 receptors.
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